Delphi Management Inc. MA Sells 186 Shares of Cabot Co. (NYSE:CBT)

Delphi Management Inc. MA reduced its stake in Cabot Co. (NYSE:CBT) by 1.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 13,878 shares of the specialty chemicals company’s stock after selling 186 shares during the quarter. Delphi Management Inc. MA’s holdings in Cabot were worth $1,267,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CBT. First Horizon Advisors Inc. lifted its position in shares of Cabot by 22.0% during the 3rd quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company’s stock valued at $73,000 after acquiring an additional 117 shares during the period. GAMMA Investing LLC raised its stake in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock valued at $123,000 after purchasing an additional 130 shares in the last quarter. Personal CFO Solutions LLC lifted its position in Cabot by 3.3% during the fourth quarter. Personal CFO Solutions LLC now owns 4,285 shares of the specialty chemicals company’s stock worth $391,000 after purchasing an additional 137 shares during the period. Moran Wealth Management LLC grew its stake in Cabot by 0.3% during the third quarter. Moran Wealth Management LLC now owns 62,116 shares of the specialty chemicals company’s stock worth $6,943,000 after buying an additional 178 shares in the last quarter. Finally, Isthmus Partners LLC increased its holdings in Cabot by 4.8% in the 4th quarter. Isthmus Partners LLC now owns 4,072 shares of the specialty chemicals company’s stock valued at $372,000 after buying an additional 187 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CBT. Mizuho cut their price target on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. cut their target price on Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, February 21st. Finally, StockNews.com lowered Cabot from a “buy” rating to a “hold” rating in a research note on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $97.00.

Cabot Trading Up 0.9 %

Shares of Cabot stock opened at $84.05 on Tuesday. The firm’s 50 day moving average is $86.73 and its 200 day moving average is $99.29. The firm has a market capitalization of $4.56 billion, a PE ratio of 11.16, a price-to-earnings-growth ratio of 0.74 and a beta of 1.21. Cabot Co. has a 1 year low of $79.57 and a 1 year high of $117.46. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT) last posted its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities research analysts forecast that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a $0.43 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 annualized dividend and a yield of 2.05%. Cabot’s dividend payout ratio is presently 22.84%.

Cabot declared that its board has initiated a stock buyback plan on Tuesday, December 3rd that permits the company to repurchase 10,000,000 shares. This repurchase authorization permits the specialty chemicals company to buy shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.